These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Serum retinol-binding protein 4 in patients with nonalcoholic fatty liver disease: does it have a significant impact on pathogenesis? Cengiz C; Ardicoglu Y; Bulut S; Boyacioglu S Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):813-9. PubMed ID: 19820404 [TBL] [Abstract][Full Text] [Related]
12. Serum chemerin and vaspin in non-alcoholic fatty liver disease. Kukla M; Zwirska-Korczala K; Hartleb M; Waluga M; Chwist A; Kajor M; Ciupinska-Kajor M; Berdowska A; Wozniak-Grygiel E; Buldak R Scand J Gastroenterol; 2010; 45(2):235-42. PubMed ID: 20095887 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease. Gangarapu V; Ince AT; Baysal B; Kayar Y; Kılıç U; Gök Ö; Uysal Ö; Şenturk H Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):840-5. PubMed ID: 26043290 [TBL] [Abstract][Full Text] [Related]
14. Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease. Yilmaz Y; Kurt R; Gurdal A; Alahdab YO; Yonal O; Senates E; Polat N; Eren F; Imeryuz N; Oflaz H Atherosclerosis; 2011 Jul; 217(1):125-9. PubMed ID: 21513939 [TBL] [Abstract][Full Text] [Related]
15. A novel model using mean platelet volume and neutrophil to lymphocyte ratio as a marker of nonalcoholic steatohepatitis in NAFLD patients: multicentric study. Abdel-Razik A; Mousa N; Shabana W; Refaey M; ElMahdy Y; Elhelaly R; Elzehery R; Zalata K; Arafa M; Elbaz S; Hafez M; Awad M Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):e1-9. PubMed ID: 26469357 [TBL] [Abstract][Full Text] [Related]
16. Prediction of Nonalcoholic Fatty Liver Disease Via a Novel Panel of Serum Adipokines. Jamali R; Arj A; Razavizade M; Aarabi MH Medicine (Baltimore); 2016 Feb; 95(5):e2630. PubMed ID: 26844476 [TBL] [Abstract][Full Text] [Related]
18. Hypoadiponectinaemia in nonalcoholic fatty liver disease obese women is associated with infrequent intake of dietary sucrose and fatty foods. Magalhães GC; Feitoza FM; Moreira SB; Carmo AV; Souto FJ; Reis SR; Martins MS; Gomes da Silva MH J Hum Nutr Diet; 2014 Apr; 27 Suppl 2():301-12. PubMed ID: 23790128 [TBL] [Abstract][Full Text] [Related]
19. Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis. Zhou Z; Chen H; Ju H; Sun M Lipids Health Dis; 2017 Sep; 16(1):180. PubMed ID: 28931435 [TBL] [Abstract][Full Text] [Related]
20. Circulating resistin is elevated in patients with non-alcoholic fatty liver disease and is associated with steatosis, portal inflammation, insulin resistance and nonalcoholic steatohepatitis scores. Senateş E; Colak Y; Yeşil A; Coşkunpinar E; Sahin O; Kahraman OT; Erkalma Şenateş B; Tuncer I Minerva Med; 2012 Oct; 103(5):369-76. PubMed ID: 23042372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]